Safety of recombinant human deoxyribonuclease as a rescue treatment for persistent atelectasis in newborns

Annals of Saudi Medicine

Volumn 32, Issue 2, 2012, Pages 131-136

  Fedakar, Atiye ^a   Aydogdu, Cavit ^a   Fedakar, Ali ^b   Ugurlucan, Murat ^c   Bolu, Semih ^c   Iskender, Marina ^a  

^a Atlas Hospital   (Turkey)

^b Kartal Kosuyolu Education and Research Hospital   (Turkey)

^c Duzce Ataturk State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DORNASE ALFA;

ARTICLE; ATELECTASIS; BREATHING RATE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DRUG SAFETY; FEMALE; HUMAN; MALE; MORTALITY; NEBULIZATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; THORAX RADIOGRAPHY;

ADMINISTRATION, INHALATION; DEOXYRIBONUCLEASE I; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; MALE; PROSPECTIVE STUDIES; PULMONARY ATELECTASIS; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 84865493967     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.5144/0256-4947.2012.131     Document Type: Article

References (19)

1. Guglani L, Lakshminrusimha S, Ryan RM. Transient tachypnea of the newborn. Pediatr Rev 2008;29:e59-65.
2. El Hassan NO, Chess PR, Huysman MW, Merkus PJ, de Jongste JC. Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates. Pediatrics 2001;108:468-70.
3. Küpeli S, Teksam O, Dogru D, Yurdakök M. Use of recombinant human DNase in a premature infant with recurrent atelectasis. Pediatr Int 2003;45:584-6. (Pubitemid 37430764)
4. Durward A, Forte V, Shemie SD. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus. Crit Care Med 2000;28:560-2. (Pubitemid 30120906)
5. Hendriks T, de Hoog M, Lequin MH, Devos AS, Merkus PJ. DNase and atelectasis in non-cystic fibrosis pediatric patients. Crit Care 2005;9:R351-6.
6. Friis B, Eiken M, Hornsleth A, Jensen A. Chest X-ray appearances in pneumonia and bronchiolitis. Correlation to virological diagnosis and secretory bacterial findings. Acta Paediatr Scand 1990;79:219-25. (Pubitemid 20085304)
7. Babcook CJ, Norman GR, Coblentz CL . Effect of clinical history on the interpretation of chest radiographs in childhood bronchiolitis. Invest Radiol 1993;28:214-7. (Pubitemid 23163266)
8. Nasr SZ, Kuhns LR, Brown RW, Hurwitz ME, Sanders GM, Strouse PJ. Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: A preliminary study. Pediatr Pulmonol 2001;31:377-82. (Pubitemid 32417256)
9. Erdeve O, Akin O, Caner I, Hepyanar V, Sarici SU. rhDNase rescue treatment in early neonatal atelectasis: Case report. J Ankara Univ Fac Med 2008;61:96-9.
10. Merkus PJ, de Hoog M, van Gent R, de Jongste JC. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis. Eur Respir J 2001;18:734-7. (Pubitemid 33040634)
11. Fitzgerald DA, Hilton J, Jepson B, Smith L. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis. Pediatrics 2005;116:e549-54. (Pubitemid 44542796)
12. Jones AP, Wallis CE. Recombinant human deoxyribonuclease for cystic fibrosis. Cochrane Database Syst Rev 2003;3:CD001127.
13. Suri R. The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis. BioDrugs 2005;19:135-44. (Pubitemid 40994230)
14. Kamin W, Klär-Hlawatsch B, Truebel H. Easy removal of a large mucus plug with a flexible paediatric bronchoscope after administration of rhDNase (Pulmozyme). Klin Padiatr 2006;218:88-91. (Pubitemid 43384957)
15. Riethmueller J, Kumpf M, Borth-Bruhns T, Brehm W, Wiskirchen J, Sieverding L, et al. Clinical and in vitro effect of dornase alfa in mechanically ventilated pediatric non-cystic fibrosis patients with atelectases. Cell Physiol Biochem 2009;23:205-10.
16. Erdeve O, Uras N, Atasay B, Arsan S. Efficacy and safety of nebulized recombinant human DNase as rescue treatment for persistent atelectasis in newborns: case-series. Croat Med J 2007;48:234-9. (Pubitemid 46651030)
17. Nasr SZ, Strouse PJ, Soskolne E, Maxvold NJ, Garver KA, Rubin BK, et al. Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis. Chest 2001;120:203-8. (Pubitemid 32744880)
18. Bryson HM, Sorkin EM. Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis. Drugs 1994;48:894-906.
19. Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 1994;331:637-42. (Pubitemid 24276863)